U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma
HERNDON, Thomas M, DEISSEROTH, Albert, PALMBY, Todd R, JEE, Josephine, ADAMS, William, MAHAYNI, Houda, BROWN, Janice, DORANTES, Angelica, SRIDHARA, Rajeshwari, FARRELL, Ann T, PAZDUR, Richard, KAMINSKAS, Edvardas, KANE, Robert C, KOTI, Kallappa M, ROTHMANN, Mark D, HABTEMARIAM, Bahru, BULLOCK, Julie, BRAY, Jeffrey D, HAWES, Jessica
Published in Clinical cancer research (01.09.2013)
Published in Clinical cancer research (01.09.2013)
Get full text
Journal Article
Issues in Using Progression-Free Survival When Evaluating Oncology Products
FLEMING, Thomas R, ROTHMANN, Mark D, LU, Hong Laura
Published in Journal of clinical oncology (10.06.2009)
Published in Journal of clinical oncology (10.06.2009)
Get full text
Journal Article
U.S. Food and Drug Administration Approval Summary: Omacetaxine Mepesuccinate as Treatment for Chronic Myeloid Leukemia
Alvandi, Firoozeh, Kwitkowski, Virginia E., Ko, Chia‐Wen, Rothmann, Mark D., Ricci, Stacey, Saber, Haleh, Ghosh, Debasis, Brown, Janice, Pfeiler, Erika, Chikhale, Elsbeth, Grillo, Joseph, Bullock, Julie, Kane, Robert, Kaminskas, Edvardas, Farrell, Ann T., Pazdur, Richard
Published in The oncologist (Dayton, Ohio) (01.01.2014)
Published in The oncologist (Dayton, Ohio) (01.01.2014)
Get full text
Journal Article
Continuing Reassessment of the Risks of Erythropoiesis-Stimulating Agents in Patients with Cancer
JUNEJA, Vinni, KEEGAN, Patricia, GOOTENBERG, Joseph E, ROTHMANN, Mark D, YUAN LI SHEN, LEE, Kyung Y, WEISS, Karen D, PAZDUR, Richard
Published in Clinical cancer research (01.06.2008)
Published in Clinical cancer research (01.06.2008)
Get full text
Journal Article
U.S. Food and Drug Administration Approval: Ruxolitinib for the Treatment of Patients with Intermediate and High-Risk Myelofibrosis
DEISSEROTH, Albert, KAMINSKAS, Edvardas, BULLOCK, Julie, BURKE, Laurie B, RAHMAN, Atiqur, SRIDHARA, Rajeshwari, FARRELL, Ann, PAZDUR, Richard, GRILLO, Joseph, WEI CHEN, SABER, Haleh, LU, Hong L, ROTHMANN, Mark D, BRAR, Satjit, JIAN WANG, GARNETT, Christine
Published in Clinical cancer research (15.06.2012)
Published in Clinical cancer research (15.06.2012)
Get full text
Journal Article
U.S. Food and Drug Administration Approval: Ofatumumab for the Treatment of Patients with Chronic Lymphocytic Leukemia Refractory to Fludarabine and Alemtuzumab
LEMERY, Steven J, ZHANG, Jenny, KEEGAN, Patricia, PAZDUR, Richard, ROTHMANN, Mark D, JUN YANG, EARP, Justin, HONG ZHAO, MCDOUGAL, Andrew, PILARO, Anne, CHIANG, Raymond, GOOTENBERG, Joseph E
Published in Clinical cancer research (01.09.2010)
Published in Clinical cancer research (01.09.2010)
Get full text
Journal Article
Innovations in Pediatric Therapeutics Development: Principles for the Use of Bridging Biomarkers in Pediatric Extrapolation
Fleming, Thomas R., Garnett, Christine E., Conklin, Laurie S., Corriol-Rohou, Solange, Hariharan, Sudharshan, Hsu, Daphne, Mueller-Velten, Guenther, Mulugeta, Yeruk, Portman, Ronald, Rothmann, Mark D., Stockbridge, Norman L., Wandel, Simon, Zhang, Jialu, Yao, Lynne
Published in Therapeutic innovation & regulatory science (01.01.2023)
Published in Therapeutic innovation & regulatory science (01.01.2023)
Get full text
Journal Article
Some essential considerations in the design and conduct of non-inferiority trials
Fleming, Thomas R, Odem-Davis, Katherine, Rothmann, Mark D, Li Shen, Yuan
Published in Clinical trials (London, England) (01.08.2011)
Published in Clinical trials (London, England) (01.08.2011)
Get full text
Journal Article
U.S. Food and Drug Administration Approval: Rituximab in Combination with Fludarabine and Cyclophosphamide for the Treatment of Patients with Chronic Lymphocytic Leukemia
Casak, Sandra J., Lemery, Steven J., Shen, Yuan Li, Rothmann, Mark D., Khandelwal, Aakanksha, Zhao, Hong, Davis, Gina, Jarral, Vaishali, Keegan, Patricia, Pazdur, Richard
Published in The oncologist (Dayton, Ohio) (01.01.2011)
Published in The oncologist (Dayton, Ohio) (01.01.2011)
Get full text
Journal Article
Testing in a Prespecified Subgroup and the Intent-to-Treat Population
Rothmann, Mark D., Zhang, Jenny J., Lu, Laura, Fleming, Thomas R.
Published in Drug information journal (01.03.2012)
Published in Drug information journal (01.03.2012)
Get full text
Journal Article
Missing Data in Biologic Oncology Products
Rothmann, Mark D., Koti, Kallappa, Lee, Kyung Yul, Lu, Hong Laura, Shen, Yuan Li
Published in Journal of biopharmaceutical statistics (01.11.2009)
Published in Journal of biopharmaceutical statistics (01.11.2009)
Get full text
Journal Article
On Non-inferiority Analysis Based On Delta-method Confidence Intervals
Rothmann, Mark D., Tsou, Hsiao-Hui
Published in Journal of biopharmaceutical statistics (01.08.2003)
Published in Journal of biopharmaceutical statistics (01.08.2003)
Get full text
Journal Article
Statement on P-values
Gwise, Thomas, Rothmann, Mark D., James Hung, H.M., Amatya, Anup, Rothwell, Rebecca, Wang, Sue Jane, Wu, Yute, Smith, Fraser, Weng, Yu-Ting, Andraca-Carrera, Eugenio, Grosser, Stella, Chattopadhyay, Somesh, Collins, Sylva H.
Published in Statistics in biopharmaceutical research (19.02.2021)
Published in Statistics in biopharmaceutical research (19.02.2021)
Get full text
Journal Article
A series criterion for moving maxima
Rothmann, Mark D., Russo, Ralph P.
Published in Stochastic processes and their applications (01.06.1993)
Published in Stochastic processes and their applications (01.06.1993)
Get full text
Journal Article
Maximal divergent uniform spacings
Russo, Ralph P., Rothmann, Mark D.
Published in Stochastic processes and their applications (01.10.1989)
Published in Stochastic processes and their applications (01.10.1989)
Get full text
Journal Article